Xbiotech, Inc.
Clinical trials sponsored by Xbiotech, Inc., explained in plain language.
-
New combo therapy aims to tame rheumatoid arthritis
Disease control Not yet recruitingThis study tests whether adding a new drug, natrunix, to the standard treatment methotrexate helps control moderate to severe rheumatoid arthritis better than methotrexate alone. About 108 adults who have not responded well enough to methotrexate will receive weekly injections fo…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC
-
New drug hope for back pain sufferers
Symptom relief Not yet recruitingThis study tests a new drug called vilamakitug for people with active axial spondyloarthritis, a type of inflammatory arthritis that causes back pain and stiffness. About 150 adults aged 18 to 65 with moderate to severe symptoms will receive either the drug or a placebo. The goal…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC